Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (2012) (ISBN 0309220645) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials: Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Making Better Drugs for Children with Cancer (2005) (ISBN 0309096081) Peter C. Adamson, Susan L Weiner, Joseph V. Simone, and Hellen Gelband, Editors, Committee on Shortening the Time Line for New Cancer Treatments, Institute of Medicine and the National Research Council


• Extending the Spectrum of Precompetitive Collaboration in Oncology Research: Workshop Summary (2010) (ISBN 0309156548) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995) (ISBN 0309052440) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer (2001) (ISBN 0309072832) Committee on Technologies for the Early Detection of Breast Cancer, Sharyl J. Nass, I. Craig Henderson, and Joyce C. Lashof, Editors, National Cancer Policy Board, Institute of Medicine, Division of Earth and Life Studies, National Research Council


• Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop Summary (2011) (ISBN 0309212685) Alison Mack and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine; An American Society of Clinical Oncology and Institute of Medicine Workshop


• Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis (2005) (ISBN 0309092132) Janet E. Joy, Edward E. Penhoet, and Diana B. Petitti, Editors, Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer, Institute of Medicine and National Research Council


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (2012) (ISBN 0309222141) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Nanotechnology and Oncology: Workshop Summary (2011) (ISBN 0309163218) Margie Patlak and Christine Micheel, Rapporteurs; Institute of Medicine